Ufp Technologies (UFPT) Net Cash Flow Growth (3y) (2013 - 2026)
Ufp Technologies (UFPT) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -48.90% |
| 10 | Ufp Technologies | 1.90 Bn | 1.88 Bn | 44.36 Mn | -27.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.01% |
| Dec 31, 2025 | 33.18% |
| Sep 30, 2025 | -10.66% |
| Jun 30, 2025 | -33.30% |
| Mar 31, 2025 | 26.81% |
| Dec 31, 2024 | 53.73% |
| Sep 30, 2024 | -30.19% |
| Jun 30, 2024 | 3.17% |
| Mar 31, 2024 | 75.75% |
| Dec 31, 2023 | -29.88% |
| Sep 30, 2023 | -37.98% |
| Jun 30, 2023 | -31.02% |
| Mar 31, 2023 | -16.15% |
| Dec 31, 2022 | 8.81% |
| Sep 30, 2022 | -10.40% |
| Jun 30, 2022 | -9.72% |
| Mar 31, 2022 | -115.98% |
| Dec 31, 2021 | -128.17% |
| Sep 30, 2021 | 75.56% |
| Jun 30, 2021 | 84.31% |